A recent uproar caused by former President Donald Trump's use of the term "bloodbath" during a rally in Dayton, Ohio. Trump warned of a "bloodbath" for the auto industry and the country if he is not re-elected, citing potential economic fallout under President Joe Biden's policies. However, critics and many media outlets interpreted the comment as a broader threat of political violence, leading to widespread debate and accusations of media misinformation. We'll explore the different interpretations of Trump's remarks, the media's role in shaping the narrative, and the public's reaction on social media platforms. Join us as we cut through the noise to understand what Trump actually said, the context of his comments, and the implications for political discourse and media integrity. ... https://www.youtube.com/watch?v=X2QQLWHZ5Qs

West Texas Doctor Claims of ‘Silver Bullet’ Off-Label Use of Inhaled Steroid as COVID-19 Treatment: A local West Texas doctor believes he has come up with an approach to effectively treat #COVID19. Dr. Richard Bartlett has practiced medicine in Texas for 28 years, and according to his claims, he advised ex-Governor of Texas, Rick Perry for several years. Now, Dr. Bartlett does a regular weekly radio update on COVID-19 in West Texas, and recently, he found himself embroiled in controversy when he declared that that the treatment of inhaled steroid (ICS) #Budesonide is a ‘silver bullet’ for treating COVID-19. So let’s take a step back here and make a few points here. First, the doctor knows all too well the politics and regulatory considerations of the U.S. healthcare system and as such, he must know that making claims this soon in his study is bound to stir up controversy within these systems. Second, he is not alone in considering this approach, as world-renowned universities such as England’s Oxford University are also studying this type of regimen. Third, and this is important for those who may want to just dismiss this out of hand, as Dr. Bartlett is part of a movement of community doctors demonstrating practical potential approaches to reducing the severity of the pandemic, any real-world data should be embraced rather than ridiculed, and if it turns out promising, rapidly incorporated into research. And Fourth, that certain societal forces will pounce on one mistake in messaging in an attempt to tarnish an entire real-world approach with promise, which evidences just how politicalized health and medicine has become in the age of COVID-19. https://www.trialsitenews.com/west-texas-doctor-flirts-with-trouble-making-claims-of-silver-bullet-off-label-use-of-inhaled-steroid-as-covid-19-treatment/ The Italian ‘COVER Trial’ has Regional Hospital & Pharma Research Institute Investigate #Ivermectin for Early Stage COVID-19: IRCCS Sacred Heart Don Calabria Hospital is an accredited Italian provider in the Veneto region that accommodates about 30,000 patients per year, includes 968 beds and employs approximately 1,712. The regional provider has come together with Mario Negri Institute for Pharmacological Research, a nonprofit research institute dedicated to clinical and biomedical research, to conduct the ‘COVER trial’, a 102 patient, prospective, multi-center, randomized, double-blind trial to assess efficacy and safety of Ivermectin for the treatment of initial infection with SARS-CoV-2 infection. Led by infectious and tropical disease expert Dr. Zeno Bisoffi, the study nears launch and will be conducted through August with final reports planned for October 2020. The study will span regions of Italy and Spain. https://www.trialsit ... https://www.youtube.com/watch?v=eFCzeBiV3nc

Scientific Research Growth and Misconduct in China—Is it a Problem? Cleveland Clinic Physician’s Personalized-Stents Approved by the FDA Driving Spin-Off Venture. FDA Approves More Drugs & Faster but Are Drugs Better and Patients Safer? AstraZeneca to Close Phase III STRENGTH trial for Epanova Upon Recommendation from Independent Data Monitoring Committee. Cell and Gene Therapy-based Clinical Trials’ Rapid Growth in the UK. How Clinical Trial Sponsors Manage their Critical Documentation: A Recent Acquisition. Sacramento CA’s Clinical Trials Research Recruit Participants for Multi-Site Study Centering on Heat Flashes from Menopause. Cancer Immunotherapy Likely Safe for those with Chronic Infections Reports Georgetown University Retrospective Study. CytoDyn Files for Breakthrough Therapy Designation with FDA for Use of Leronlimab for Metastatic Triple-Negative Breast Cancer. Does Kyverna Therapeutics Gilead Financing Introduce Disruptive Cell Therapy Platform to Attack Autoimmune Disease? Hebrew University’s Hadassah Medical Center Spin-off Developing Type 2 Diabetes Drug. MRC London Institute of Medical Sciences with Breakthrough in Understanding Schizophrenia. CLINICAL CHALLENGES 00.31 CLINICAL TRIAL 01.51 CANCER 04.44 AUTOIMMUNE 05.46 DIABETES 06.19 MENTAL HEALTH 06.49 ... https://www.youtube.com/watch?v=anToNW-66BY

TrialSite News’ interview with Tarek Alam, head of medicine department at Bangladesh Medical College, has led to considerable interest in regional hospital protocol-approved, off-label use of #ivermectin and the antibiotic #Doxycycline in patients diagnosed with mild cases of #COVID-19. Thus far, Dr. Alam reaffirmed to TrialSite News their “outstanding results.” A number of developing economy-based nations are embracing ivermectin as a low-cost approach to fighting at least mild cases of COVID-19—despite the lack of data from randomized controlled trials. He has acknowledged in the TrialSite News interview that randomized controlled trials are needed and that at least in Bangladesh that comes next. But he is reasonably certain ivermectin is a path forward as one treatment for COVID-19. ... https://www.youtube.com/watch?v=Q7pqyKGsgJU